Skip to main content
. 2000 May;66(5):2259–2262. doi: 10.1128/aem.66.5.2259-2262.2000

TABLE 1.

Average plaque counts

Serum typea Avg plaque count (107 PFU/ml) forb:
Rank
PV1 PV2 PV3 CA7 CB3 CB4 CB5 E7 E11
FBS 53.8 (16.1) 2.81 (1.0) 18.8 (7.46) 0.296 (0.609) 3.38 (0.79) 4.5 (0.94) 19.6 (6.65) 21 (9.49) 14.5 (3.53) 1.222
CPSR-1 50.2 (15.1) 2.96 (1.39) 13.7 (5.03) 0.32 (0.763) 3.69 (0.99) 3.49 (1.06) 10.6 (3.0) 4.41 (2.33) 9.48 (2.04) 1.666
NS4 28.6 (5.86) 1.19 (0.81) 12.8 (5.29) 0.136 (0.448) 1.09 (0.37) 0.52 (0.34) 4.40 (2.1) 18.8 (6.2) 9.98 (2.69) 2.333
FC3 30.3 (9.18) 1.54 (0.6) 16.8 (8.39) 0.25 (0.371) 4.76 (1.29) 3.28 (1.05) 17.2 (4.17) 9.61 (2.57) 8.57 (3.55) 1.777
Serum + NAc NA NA NA NA NA NA NA NA NA
a

NS4, Nuserum IV; FC3, FetalClone III; Serum +, Serum Plus. 

b

Values in parentheses are standard deviations. PV1, poliovirus type 1; PV2, poliovirus type 2; PV3, poliovirus type 3; CA7, coxsackievirus A7 (Russian); CB3, coxsackievirus B3 (Nancy); CB4, coxsackievirus B4 (Benschoten); CB5, cocksackievirus B5 (Faulkner); E7, echovirus type 7 (Wallace); E11, echovirus type 11 (Gregory). 

c

NA, not available (Serum Plus was not tested in this assay).